Explore more publications!
Africa News Observer
Got News to Share?

Africa News Observer: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Africa News Observer.

November 2025

Mo Tu We Th Fr Sa Su
1 2
3 4 5 6 7 8 9
10 11 12 13 14 15 16
17 18 19 20 21 22 23
24 25 26 27 28 29 30

December 2025

Mo Tu We Th Fr Sa Su
1 2 3 4 5 6 7
8 9 10 11 12 13 14
15 16 17 18 19 20 21
22 23 24 25 26 27 28
29 30 31

January 2026

Mo Tu We Th Fr Sa Su
1 2 3 4
5 6 7 8 9 10 11
12 13 14 15 16 17 18
19 20 21 22 23 24 25
26 27 28 29 30 31

Press releases published on January 5, 2026

BridgeBio to Participate in the J.P. Morgan Healthcare Conference
January 5, 2026

BridgeBio to Participate in the J.P. Morgan Healthcare Conference

Indeterminate GlobeNewswire
Copperhead Resources Announces Changes in Officers
January 5, 2026

Copperhead Resources Announces Changes in Officers

Indeterminate GlobeNewswire
Altimmune Receives FDA Breakthrough Therapy Designation for Pemvidutide in MASH
January 5, 2026

Altimmune Receives FDA Breakthrough Therapy Designation for Pemvidutide in MASH

Indeterminate GlobeNewswire
Zenas BioPharma Announces Positive Results from Phase 3 INDIGO Registrational Trial of Obexelimab in Immunoglobulin G4-Related Disease (IgG4-RD)
January 5, 2026

Zenas BioPharma Announces Positive Results from Phase 3 INDIGO Registrational Trial of Obexelimab in Immunoglobulin G4-Related Disease (IgG4-RD)

Indeterminate GlobeNewswire
Maze Therapeutics to Participate in the 44th Annual J.P. Morgan Healthcare Conference
January 5, 2026

Maze Therapeutics to Participate in the 44th Annual J.P. Morgan Healthcare Conference

Indeterminate GlobeNewswire
Apellis Pharmaceuticals to Present at the 44th Annual J.P. Morgan Healthcare Conference
January 5, 2026

Apellis Pharmaceuticals to Present at the 44th Annual J.P. Morgan Healthcare Conference

Indeterminate GlobeNewswire
Agios to Present at the 44th Annual J.P. Morgan Healthcare Conference on January 14, 2026
January 5, 2026

Agios to Present at the 44th Annual J.P. Morgan Healthcare Conference on January 14, 2026

Indeterminate GlobeNewswire
Tango Therapeutics Appoints Sung Lee to Board of Directors
January 5, 2026

Tango Therapeutics Appoints Sung Lee to Board of Directors

Indeterminate GlobeNewswire
Copper Quest Acquires 100% Interest in the Kitimat Copper-Gold Project
January 5, 2026

Copper Quest Acquires 100% Interest in the Kitimat Copper-Gold Project

Indeterminate GlobeNewswire
Stallion Uranium Announces Mobilization for Winter Drilling Program, Appoints Paulo Santos as Chief Financial Officer
January 5, 2026

Stallion Uranium Announces Mobilization for Winter Drilling Program, Appoints Paulo Santos as Chief Financial Officer

Indeterminate GlobeNewswire
MapLight Therapeutics Receives Fast Track Designation for ML-007C-MA for Alzheimer’s Disease Psychosis
January 5, 2026

MapLight Therapeutics Receives Fast Track Designation for ML-007C-MA for Alzheimer’s Disease Psychosis

Indeterminate GlobeNewswire
OKYO Pharma Appoints Industry Veteran Robert J. Dempsey as Chief Executive Officer
January 5, 2026

OKYO Pharma Appoints Industry Veteran Robert J. Dempsey as Chief Executive Officer

Indeterminate GlobeNewswire
Crescent Biopharma Announces Regulatory Clearances of IND Applications for CR-001, a PD-1 x VEGF Bispecific Antibody and CR-003, an ITGB6-targeted ADC, for the Treatment of Solid Tumors
January 5, 2026

Crescent Biopharma Announces Regulatory Clearances of IND Applications for CR-001, a PD-1 x VEGF Bispecific Antibody and CR-003, an ITGB6-targeted ADC, for the Treatment of Solid Tumors

Indeterminate GlobeNewswire
Neumora Therapeutics Highlights 2026 Pipeline Strategy and Anticipated Upcoming Milestones
January 5, 2026

Neumora Therapeutics Highlights 2026 Pipeline Strategy and Anticipated Upcoming Milestones

Indeterminate GlobeNewswire
Neumora Therapeutics Announces Positive Results from NMRA-511 Phase 1b Signal-Seeking Study in Alzheimer’s Disease Agitation
January 5, 2026

Neumora Therapeutics Announces Positive Results from NMRA-511 Phase 1b Signal-Seeking Study in Alzheimer’s Disease Agitation

Indeterminate GlobeNewswire
NorthWest Reports Near-Surface Intersept of 25.9 Metres Grading 0.91 % Cu, 1.29 g/t Au (2.09% CuEq) From 154 Metres
January 5, 2026

NorthWest Reports Near-Surface Intersept of 25.9 Metres Grading 0.91 % Cu, 1.29 g/t Au (2.09% CuEq) From 154 Metres

Indeterminate GlobeNewswire
Titan Mining Delivers on Planned De-leveraging Strengthening Balance Sheet for Graphite Growth
January 5, 2026

Titan Mining Delivers on Planned De-leveraging Strengthening Balance Sheet for Graphite Growth

Indeterminate GlobeNewswire
MEXC Launches "Galaxy Quest" Trading Event with Up to 1,000 USDT in Rewards
January 5, 2026

MEXC Launches "Galaxy Quest" Trading Event with Up to 1,000 USDT in Rewards

Indeterminate GlobeNewswire
HUTCHMED Initiates Phase III Stage of the Ongoing Trial of the Combination of Surufatinib and Camrelizumab for Treatment-Naïve Pancreatic Ductal Adenocarcinoma
January 5, 2026

HUTCHMED Initiates Phase III Stage of the Ongoing Trial of the Combination of Surufatinib and Camrelizumab for Treatment-Naïve Pancreatic Ductal Adenocarcinoma

Indeterminate GlobeNewswire

Share us

on your social networks:
Facebook Facebook LinkedIn LinkedIn
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions